Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Chinese Patent Office
Harvard Business School
Merck
Mallinckrodt

Generated: March 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Varespladib methyl

« Back to Dashboard

US Patents for Varespladib methyl

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Varespladib methyl ➤ Sign Up 1H-indole-3-glyoxylamide SPLA.sub.2 inhibitors Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Varespladib methyl ➤ Sign Up 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Varespladib methyl ➤ Sign Up 1H-indole-3-glyoxylamide sPLA.sub.2 inhibitors Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Varespladib methyl ➤ Sign Up Process for preparing 1H-indole-3-glyoxylamides Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Varespladib methyl ➤ Sign Up Method for treatment of chronic bronchitis using indole compounds Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Varespladib methyl ➤ Sign Up Process for preparing 4-substituted-1H-indole-3-glyoxamides Eli Lilly and Company (Indianapolis, IN) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Varespladib methyl

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Varespladib methyl Austria 220394 2014-04-01 ➤ Sign Up
Varespladib methyl Austria 540923 2014-04-01 ➤ Sign Up
Varespladib methyl Australia 1621795 2014-04-01 ➤ Sign Up
Varespladib methyl Australia 688458 2014-04-01 ➤ Sign Up
Varespladib methyl Brazil 9501404 2014-04-01 ➤ Sign Up
Varespladib methyl Canada 2146097 2014-04-01 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
McKinsey
Julphar
US Department of Justice
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: